康希诺宇学峰:科创板助力,创新研发穿越“死亡之谷”

贝果财经
Dec 19, 2025

中经记者 罗辑 北京报道“科创板的支持是我们穿越生物医药创新研发‘死亡之谷’的关键保障。”康希诺(688185.SH)联合创始人、董事长兼首席执行官宇学峰日前做客《沪市汇·硬科硬客》第二季第7期节目“科创成长层‘成长记’”时介绍,2025年前三季度,康希诺实现扭亏为盈,成为科创板首个“摘U”的生物科技企业。康希诺联合创始人、董事长生物医药行业具有长周期、高投入、高风险的显著特征,尤其在疫苗研发领域...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10